Basic Information
| RNALocate ID: | RLID:11003789 |
| RNA Symbol: | hsa-miR-150-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-150-3p |
| RNA ID: | miRBase:MIMAT0004610 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003787 | Exosome | Saliva | 19627513 |
| RLID:11003788 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11003790 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000640 | Microvesicle | Colon cancer cell line (LIM1863)|Mesenchymal stem cells | |
| RLID-D:11001515 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-150-3p | Medulloblastoma | MNDR-E-MI-16510 |
| MNDR | hsa-miR-150-3p | B cell lymphoma of malt type | MNDR-E-MI-16511 |
| MNDR | hsa-miR-150-3p | Lymphoma | MNDR-E-MI-16512 |
| MNDR | hsa-miR-150-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-16513 |
| MNDR | hsa-miR-150-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-16514 |
| MNDR | hsa-miR-150-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-16515 |
| MNDR | hsa-miR-150-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-16516 |
| MNDR | hsa-miR-150-3p | Her2-receptor positive breast cancer | MNDR-E-MI-16517 |
| MNDR | hsa-miR-150-3p | Breast cancer luminal | MNDR-E-MI-16518 |
| MNDR | hsa-miR-150-3p | Prostate cancer | MNDR-E-MI-16519 |
| MNDR | hsa-miR-150-3p | Gastric cancer | MNDR-E-MI-16520 |
| MNDR | hsa-miR-150-3p | Intracranial aneurysm | MNDR-E-MI-16521 |
| MNDR | hsa-miR-150-3p | Lung cancer | MNDR-E-MI-16522 |
| MNDR | hsa-miR-150-3p | Biliary atresia | MNDR-E-MI-16523 |
| MNDR | hsa-miR-150-3p | Parkinson disease | MNDR-E-MI-16524 |
| MNDR | hsa-miR-150-3p | Basal-like breast cancer | MNDR-E-MI-16525 |
| MNDR | hsa-miR-150-3p | Pancreatic cancer | MNDR-E-MI-16526 |
| MNDR | hsa-miR-150-3p | Rectum adenocarcinoma | MNDR-E-MI-16527 |
| MNDR | hsa-miR-150-3p | Nephroblastoma | MNDR-E-MI-16528 |
| MNDR | hsa-miR-150-3p | Colon cancer | MNDR-E-MI-16529 |
| MNDR | hsa-miR-150-3p | Colon adenocarcinoma | MNDR-E-MI-16530 |
| MNDR | hsa-miR-150-3p | Familial ovarian cancer | MNDR-E-MI-16531 |
| MNDR | hsa-miR-150-3p | Carcinoma ductal breast | MNDR-E-MI-16532 |
| MNDR | hsa-miR-150-3p | Glioblastoma | MNDR-E-MI-16533 |
| MNDR | hsa-miR-150-3p | Astrocytoma | MNDR-E-MI-16534 |
| MNDR | hsa-miR-150-3p | Chordoma | MNDR-E-MI-16535 |
| MNDR | hsa-miR-150-3p | Osteosarcoma | MNDR-E-MI-16536 |
| MNDR | hsa-miR-150-3p | Infarction middle cerebral artery | MNDR-E-MI-16537 |
| MNDR | hsa-miR-150-3p | Liver cancer | MNDR-E-MI-16538 |
| MNDR | hsa-miR-150-3p | Gastric adenocarcinoma | MNDR-E-MI-16539 |
| MNDR | hsa-miR-150-3p | Lung squamous cell carcinoma | MNDR-E-MI-16540 |
| MNDR | hsa-miR-150-3p | Lung adenocarcinoma | MNDR-E-MI-16541 |
| MNDR | hsa-miR-150-3p | Thyroid carcinoma | MNDR-E-MI-16542 |
| MNDR | hsa-miR-150-3p | Bladder urothelial carcinoma | MNDR-E-MI-16543 |
| MNDR | hsa-miR-150-3p | Pancreatic adenocarcinoma | MNDR-E-MI-16544 |
| MNDR | hsa-miR-150-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-16545 |
| MNDR | hsa-miR-150-3p | Renal clear cell carcinoma | MNDR-E-MI-16546 |
| MNDR | hsa-miR-150-3p | Biliary tract cancer | MNDR-E-MI-16547 |
| MNDR | hsa-miR-150-3p | Cholangiocarcinoma | MNDR-E-MI-16548 |
| MNDR | hsa-miR-150-3p | Esophageal cancer | MNDR-E-MI-16549 |
| MNDR | hsa-miR-150-3p | Lung small cell carcinoma | MNDR-E-MI-16550 |
| MNDR | hsa-miR-150-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-16551 |
| MNDR | hsa-miR-150-3p | Testicular germ cell cancer | MNDR-E-MI-16552 |
| MNDR | hsa-miR-150-3p | Myocardial infarction | MNDR-E-MI-16553 |
| MNDR | hsa-miR-150-3p | Breast invasive carcinoma | MNDR-E-MI-16554 |
| MNDR | hsa-miR-150-3p | Hepatocellular carcinoma | MNDR-E-MI-16555 |
| MNDR | hsa-miR-150-3p | Embryonal cancer | MNDR-E-MI-16556 |
| MNDR | hsa-miR-150-3p | Familiar ovarian carcinoma | MNDR-E-MI-16557 |
| MNDR | hsa-miR-150-3p | B-cell lymphoma | MNDR-E-MI-16558 |
| MNDR | hsa-miR-150-3p | Hodgkin lymphoma | MNDR-E-MI-16559 |
| MNDR | hsa-miR-150-3p | Skin cutaneous melanoma | MNDR-E-MI-16560 |
| MNDR | hsa-miR-150-3p | Skin melanoma | MNDR-E-MI-16561 |
| MNDR | hsa-miR-150-3p | Colorectal cancer | MNDR-E-MI-16562 |
| MNDR | hsa-miR-150-3p | Nasopharynx carcinoma | MNDR-E-MI-16563 |
| MNDR | hsa-miR-150-3p | Multiple myeloma | MNDR-E-MI-16564 |
| MNDR | hsa-miR-150-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-16565 |
| MNDR | hsa-miR-150-3p | Nasopharyngeal cancer | MNDR-E-MI-16566 |
| MNDR | hsa-miR-150-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-16567 |
| MNDR | hsa-miR-150-3p | Breast cancer her3+ negative | MNDR-E-MI-16568 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CCNT1 | Homo sapiens | RR00296614 |
TOP